Olivier Decaux, Jean Fontan, Aurore Perrot, Lionel Karlin, Cyrille Touzeau, Samantha Schulmann, Salomon Manier, Karim Belhadj, Adrien Trebouet, Patricia Zunic, Jean-Marc Schiano De Colella, Brice Castel, Zoé Van De Wyngaert, Gian Matteo Pica, Mourad Tiab, Frédérique Kuhnowski, Malek Bouketouche, Sophia Rigaudeau, Riad Benramdane, Christina Tekle, Radhia Lafore, Marianne Gaucher, Jill Corre, Xavier Leleu
BACKGROUND: IMAGE is a retrospective cohort study of patients enrolled in early access programs (EAPs) in France with relapsed/refractory multiple myeloma (RRMM) receiving isatuximab with pomalidomide and dexamethasone (Isa-Pd). METHODS: Patients aged ≥18 years with RRMM who received ≥1 dose of Isa under the EAPs between July 29, 2019 and August 30, 2020 were included. Effectiveness endpoints included progression-free survival (PFS) and response rates...
May 7, 2024: European Journal of Haematology